COVID-19 IgG xPOC

About Genspeed Biotech

Genspeed Biotech is a privately held diagnostics company commercializing a rapid, multiplex immunoassay platform for point-of-care (POC) testing. Its core technology, the GENSPEED xPOC, allows for lab-quality quantification of multiple biomarkers from minimal blood volume, targeting the growing demand for decentralized, personalized diagnostics. The company has transitioned to a revenue-generating stage with a dual business model: selling its own branded tests (e.g., Vitamin D, COVID-19 IgG, TBE IgG) and licensing its IVDR-certified OEM platform to other diagnostic manufacturers. Its strategic focus is on enabling rapid results to drive clinical and consumer health decisions.

Therapeutic Areas